1. Microarray‑based analysis of COL11A1 and TWIST1 as important differentially‑expressed pathogenic genes between left and right‑sided colon cancer
    Chen Su et al, 2019, Molecular Medicine Reports CrossRef
  2. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
    Bernhard Mlecnik et al, 2016, Science Translational Medicine CrossRef
  3. Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas
    George Kunnackal John et al, 2021, Familial Cancer CrossRef
  4. Integrative molecular analysis of colorectal cancer and gastric cancer: What have we learnt?
    Avani Athauda et al, 2019, Cancer Treatment Reviews CrossRef
  5. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients
    Pan Li et al, 2017, PLOS ONE CrossRef
  6. Tumor location as a novel high risk parameter for stage II colorectal cancers
    Biyuan Wang et al, 2017, PLOS ONE CrossRef
  7. Hemicolectomy Does Not Provide Survival Benefit for Right-Sided Mucinous Colon Adenocarcinoma
    Jia Huang et al, 2021, Frontiers in Oncology CrossRef
  8. Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon
    Joel Pekow et al, 2015, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
  9. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study
    Rashmi Sinha et al, 2012, The American Journal of Clinical Nutrition CrossRef
  10. Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer
    Yayoi Takahashi et al, 2016, International Journal of Cancer CrossRef
  11. Molecular alterations in colorectal adenomas and intramucosal adenocarcinomas defined by high-density single-nucleotide polymorphism arrays
    Makoto Eizuka et al, 2017, Journal of Gastroenterology CrossRef
  12. Immune Characters and Plasticity of the Sentinel Lymph Node in Colorectal Cancer Patients
    Xiaoyun Li et al, 2021, Journal of Immunology Research CrossRef
  13. Detection of Polyps After Resection of Colorectal Cancer
    Jin-Hee Paik et al, 2015, Annals of Coloproctology CrossRef
  14. Expression of cyclin E in stage III colorectal carcinoma
    LEA RATH-WOLFSON et al, 2013, Oncology Letters CrossRef
  15. Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study
    Lara Pozzuto et al, 2021, Frontiers in Oncology CrossRef
  16. Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
    Robert E. Schoen et al, 2012, New England Journal of Medicine CrossRef
  17. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
    S.Y. Brulé et al, 2015, European Journal of Cancer CrossRef
  18. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy
    M K H Maus et al, 2015, The Pharmacogenomics Journal CrossRef
  19. Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesis
    Joshua D. G. Leach et al, 2021, Nature Communications CrossRef
  20. Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study
    Malgorzata Krzystek-Korpacka et al, 2012, International Journal of Colorectal Disease CrossRef
  21. Molecular Origins of Colon and Rectal Cancer: Not a Wnt–Wnt Situation
    Murali D. Bashyam et al, 2013, Current Colorectal Cancer Reports CrossRef
  22. Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients
    P A Candy et al, 2013, British Journal of Cancer CrossRef
  23. Association between time to colonoscopy after a positive guaiac fecal test result and risk of colorectal cancer and advanced stage disease at diagnosis
    Amani Beshara et al, 2020, International Journal of Cancer CrossRef
  24. Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas
    Suzanne M. Crumley et al, 2016, Archives of Pathology & Laboratory Medicine CrossRef
  25. Colon and Rectal Cancer Survival by Tumor Location and Microsatellite Instability
    Amanda I. Phipps et al, 2013, Diseases of the Colon & Rectum CrossRef
  26. Características clínicas, anatomopatológicas y moleculares en casos de cáncer colorrectal según localización tumoral y grado de diferenciación
    Laura Vilorio-Marqués et al, 2015, Revista Colombiana de Cancerología CrossRef
  27. The clinical perspectives of CDX2 expression in colorectal cancer: A qualitative systematic review
    J. Olsen et al, 2014, Surgical Oncology CrossRef
  28. Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm
    Éanna J. Ryan et al, 2020, Frontiers in Oncology CrossRef
  29. CD44v6 engages in colorectal cancer progression
    Lixin Ma et al, 2019, Cell Death & Disease CrossRef
  30. Building Multi-Marker Algorithms for Disease Prediction–-The Role of Correlations among Markers
    Paul F. Pinsky et al, 2011, Biomarker Insights CrossRef
  31. Clinical significance of circulating immune cells in left- and right-sided colon cancer
    Jiabo Di et al, 2017, PeerJ CrossRef
  32. Predictors of lymph-node metastasis in surgically resected T1 colorectal cancer in Western populations
    Zhen Zong et al, 2021, Gastroenterology Report CrossRef
  33. Proteome Heterogeneity in Colorectal Cancer
    Lay Cheng Lim et al, 2018, PROTEOMICS CrossRef
  34. Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review
    Nicolas Silva-Illanes et al, 2018, Value in Health CrossRef
  35. The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
    Daeyoun David Won et al, 2017, BMC Cancer CrossRef
  36. Colorectal cancer survival at an oncologic center in Colombia. A historic cohort study
    S.M. Campo-Sánchez et al, 2019, Revista de Gastroenterología de México (English Edition) CrossRef
  37. Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy
    Dengbo Ji et al, 2018, Cancer Immunology Research CrossRef
  38. Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case–control study
    Thomas Broughton et al, 2012, BMC Gastroenterology CrossRef
  39. Plasma protein expression differs between colorectal cancer patients depending on primary tumor location
    Matilda Holm et al, 2020, Cancer Medicine CrossRef
  40. A Pooled Analysis of Smoking and Colorectal Cancer: Timing of Exposure and Interactions with Environmental Factors
    Jian Gong et al, 2012, Cancer Epidemiology Biomarkers & Prevention CrossRef
  41. Mutational analysis and clinical correlation of metastatic colorectal cancer
    Andrea L. Russo et al, 2014, Cancer CrossRef
  42. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer
    Arul E. Suthananthan et al, 2018, ANZ Journal of Surgery CrossRef
  43. Analysis of clinicopathological features and prognosis of 1315 cases in colorectal cancer located at different anatomical subsites
    Zhen Feng et al, 2019, Pathology - Research and Practice CrossRef
  44. Quantification of Micrornas by Absolute Dpcr for the Diagnostic Screening of Colon Cancer
    Farid E. Ahmed et al, 2019, Journal Of Colon And Rectal Cancer CrossRef
  45. Helicobacter pylori Infection and Colorectal Cancer Risk: Evidence From a Large Population-based Case-Control Study in Germany
    Y. Zhang et al, 2012, American Journal of Epidemiology CrossRef
  46. Comparison of biomarker expression between proximal and distal colorectal adenomas: The Tennessee-Indiana Adenoma Recurrence Study
    Timothy Su et al, 2017, Molecular Carcinogenesis CrossRef
  47. Comparative proteomic study for profiling differentially expressed proteins between Chinese left- and right-sided colon cancers
    Hong Shen et al, 2013, Cancer Science CrossRef
  48. Differential expression of TNF-α signaling molecules and ERK1 in distal and proximal colonic tumors associated with obesity
    Swati S. Jain et al, 2011, Tumor Biology CrossRef
  49. Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells
    Girolamo Spagnoletti et al, 2018, Tumor Biology CrossRef
  50. Microbial Interactions and Interventions in Colorectal Cancer
    Terence Van Raay et al, 2017, Microbiology Spectrum CrossRef
  51. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis
    Yamei Zhao et al, 2019, World Journal of Surgical Oncology CrossRef
  52. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study
    Xu Guan et al, 2015, PLOS ONE CrossRef
  53. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer
    Anqi Lin et al, 2020, Frontiers in Immunology CrossRef
  54. CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
    Matilde Todaro et al, 2014, Cell Stem Cell CrossRef
  55. CDX2 and Muc2 immunohistochemistry as prognostic markers in stage II colon cancer
    Matthew J. Cecchini et al, 2019, Human Pathology CrossRef
  56. Statin use is associated with a reduced incidence of colorectal adenomatous polyps
    Thomas Broughton et al, 2013, International Journal of Colorectal Disease CrossRef
  57. Prognostic factors for overall survival in metastatic colorectal cancer using a stop-and-go FLIRI-based treatment strategy
    Camilla S. Kronborg et al, 2015, International Journal of Colorectal Disease CrossRef
  58. Molecular Parameters for Prognostic and Predictive Assessment in Colorectal Cancer
    Alessandro Carrer et al, 2013, Rectal Cancer CrossRef
  59. Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies
    C-W Fan et al, 2013, Cell Death & Disease CrossRef
  60. Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk
    Derek V. Seidel et al, 2017, Seminars in Cancer Biology CrossRef
  61. Supervivencia de cáncer colorrectal en un centro oncológico de Colombia. Estudio de cohorte histórica
    S.M. Campo-Sánchez et al, 2019, Revista de Gastroenterología de México CrossRef
  62. Higher prevalence of KRAS mutations in colorectal cancer in Saudi Arabia: Propensity for lung metastasis
    Talha Bader et al, 2014, Alexandria Journal of Medicine CrossRef
  63. Adjuvant chemotherapy
    B. Glimelius, 2013, European Journal of Cancer Supplements CrossRef
  64. Segmental distribution of some common molecular markers for colorectal cancer (CRC): influencing factors and potential implications
    Petros Christakis Papagiorgis, 2016, Tumor Biology CrossRef
  65. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program
    Géoffroy Frank Azimafoussé Assogba et al, 2015, Cancer Epidemiology CrossRef
  66. Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location
    Julia D Labadie et al, 2020, JNCI Cancer Spectrum CrossRef
  67. Colorectal cancers choosing sides
    Cristina Albuquerque et al, 2011, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  68. Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location
    Longhui Zhang et al, 2018, Frontiers in Immunology CrossRef
  69. Membranous CD44v6 is upregulated as an early event in colorectal cancer: Downregulation is associated with circulating tumor cells and poor prognosis
    Agapi Kataki et al, 2021, Oncology Letters CrossRef
  70. Rectal and colon cancer: Not just a different anatomic site
    K. Tamas et al, 2015, Cancer Treatment Reviews CrossRef
  71. KISS1 expression in colorectal cancer
    Ioannis D. Kostakis et al, 2013, APMIS CrossRef
  72. Genome-wide analysis of the rat colon reveals proximal-distal differences in histone modifications and proto-oncogene expression
    Karen Triff et al, 2013, Physiological Genomics CrossRef
  73. Molecular phenotypes of colorectal cancer and potential clinical applications
    Jonathan M. Kocarnik et al, 2015, Gastroenterology Report CrossRef
  74. Prognostic Factors of Rectal Cancer in Southern Iran
    Seyed Vahid Hosseini et al, 2020, Journal of Gastrointestinal Cancer CrossRef
  75. Racial Disparities and Sex Differences in Early- and Late-Onset Colorectal Cancer Incidence, 2001–2018
    Jessica L. Petrick et al, 2021, Frontiers in Oncology CrossRef
  76. The contribution of targeted therapy to the neoadjuvant chemoradiation of rectal cancer
    Francesco Torino et al, 2013, Critical Reviews in Oncology/Hematology CrossRef
  77. The role of mouse models in colorectal cancer research—The need and the importance of the orthotopic models
    Rui C. Oliveira et al, 2020, Animal Models and Experimental Medicine CrossRef
  78. Comparative study of mutations in SNP loci ofK-RAS,hMLH1andhMSH2genes in neoplastic intestinal polyps and colorectal cancer
    Zhi-Hui Yan, 2014, World Journal of Gastroenterology CrossRef
  79. Differences in Cancer-Specific Mortality of Right- Versus Left-Sided Colon Adenocarcinoma: A Surveillance, Epidemiology, and End Results Database Analysis
    Chenyang Wang et al, 2017, JCO Clinical Cancer Informatics CrossRef
  80. Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations
    Veronika Fedirko et al, 2014, International Journal of Cancer CrossRef
  81. The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution
    Seung Tae Kim et al, 2016, Medicine CrossRef
  82. Immune Response Gene Expression in Colorectal Cancer Carries Distinct Prognostic Implications According to Tissue, Stage and Site: A Prospective Retrospective Translational Study in the Context of a Hellenic Cooperative Oncology Group Randomised Trial
    George Pentheroudakis et al, 2015, PLOS ONE CrossRef
  83. Gallstone disease is associated with rectal cancer: a meta-analysis
    Corinna Chiong et al, 2012, Scandinavian Journal of Gastroenterology CrossRef
  84. FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue
    Frank Christian Schultze et al, 2014, Clinical Biochemistry CrossRef
  85. A clinicopathological analysis of KISS1 and KISS1R expression in colorectal cancer
    Ioannis D. Kostakis et al, 2015, APMIS CrossRef
  86. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients of colorectal cancer
    Jieyun Zhang et al, 2020, Japanese Journal of Clinical Oncology CrossRef
  87. Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer
    Jing Nan LI et al, 2012, Journal of Digestive Diseases CrossRef
  88. Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma
    Frank Benedix et al, 2012, Pathology - Research and Practice CrossRef
  89. Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data
    Yan Zhang et al, 2021, Current Medical Science CrossRef
  90. Association between Cardiovascular Risk and Diabetes with Colorectal Neoplasia: A Site-Specific Analysis
    David Niederseer et al, 2018, Journal of Clinical Medicine CrossRef
  91. Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer
    Xian Hua Gao et al, 2017, Scientific Reports CrossRef
  92. Microbial Interactions and Interventions in Colorectal Cancer
    Terence Van Raay et al, 2018, Bugs as Drugs CrossRef
  93. Longitudinal molecular characterization of endoscopic specimens from colorectal lesions
    Petra Minarikova et al, 2016, World Journal of Gastroenterology CrossRef
  94. Elevated expression of p53 in early colon polyps in a pig model of human familial adenomatous polyposis
    Agata Sikorska et al, 2018, Journal of Applied Genetics CrossRef
  95. Incidence trends and age distribution of colorectal cancer by subsite in Guangzhou, 2000–2011
    Qin Zhou et al, 2015, Chinese Journal of Cancer CrossRef
  96. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature
    George Kunnackal John et al, 2021, Familial Cancer CrossRef
  97. Development of a deregulating microRNA panel for the detection of early relapse in postoperative colorectal cancer patients
    I-Ping Yang et al, 2016, Journal of Translational Medicine CrossRef
  98. Clinical Comparison for Colon Polyps between Right and Left Colon in Koreans
    Wook Hyun Um et al, 2012, Intestinal Research CrossRef
  99. The relationship between proximal and distal colonic adenomas
    Alfredo J. Lucendo et al, 2013, European Journal of Gastroenterology & Hepatology CrossRef
  100. Association of Dietary Quercetin With Reduced Risk of Proximal Colon Cancer
    Zora Djuric et al, 2012, Nutrition and Cancer CrossRef
  101. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study
    Jonna Berntsson et al, 2017, International Journal of Cancer CrossRef
  102. TNM staging system of colorectal carcinoma: surgical pathology of the seventh edition
    Giacomo Puppa, 2011, Diagnostic Histopathology CrossRef
  103. Expression of the apoptosis inhibitor livin in colorectal adenoma-carcinoma sequence: correlations with pathology and outcome
    Y. Wang et al, 2014, Tumor Biology CrossRef
  104. Microenvironment influence on human colon adenocarcinoma phenotypes and matrix metalloproteinase-2, p53 and β-catenin tumor expressions from identical monoclonal cell tumor in the orthotopic model in athymic nude rats
    Denise Gonçalves Priolli et al, 2014, Scandinavian Journal of Gastroenterology CrossRef
  105. Will Adjuvant Chemotherapy Improve Outcome After Preoperative Chemoradiation?
    Bengt Glimelius et al, 2012, Multidisciplinary Management of Rectal Cancer CrossRef
  106. Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer
    Yuchen Guo et al, 2021, Journal of Clinical Investigation CrossRef
  107. The significance of microsatellite instability in colorectal cancer after controlling for clinicopathological factors
    Sanghee Kang et al, 2018, Medicine CrossRef
  108. Meat-Related Compounds and Colorectal Cancer Risk by Anatomical Subsite
    Paige E. Miller et al, 2013, Nutrition and Cancer CrossRef
  109. A pilot study comparing protein expression in different segments of the normal colon and rectum and in normal colon versus adenoma in patients with Lynch syndrome
    Chongjuan Wei et al, 2013, Journal of Cancer Research and Clinical Oncology CrossRef
  110. Colon cancer modulation by a diabetic environment: A single institutional experience
    Isabel Prieto et al, 2017, PLOS ONE CrossRef